Trademark Overview
On Wednesday, June 26, 2024, a trademark application was filed for VOCLEST with the United States Patent and Trademark Office. The USPTO has given the VOCLEST trademark a serial number of 98620377. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, June 26, 2024. This trademark is owned by Pfizer Inc.. The VOCLEST trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions.
